424 filings
EFFECT
BFFTF
Biofrontera AG
14 Mar 22
Notice of effectiveness
12:15am
6-K
BFFTF
Biofrontera AG
9 Mar 22
Biofrontera files Form 15F to suspend SEC Reporting Requirements and starts trading Level I ADS program on US OTC market
5:53pm
15F-12B
BFFTF
Biofrontera AG
9 Mar 22
Securities registration termination (foreign)
4:27pm
POS AM
BFFTF
Biofrontera AG
9 Mar 22
Prospectus update (post-effective amendment)
2:35pm
S-8 POS
BFFTF
Biofrontera AG
9 Mar 22
Registration of securities for employees (post-effective amendment)
2:29pm
25
oengv5r6joka3lqh
24 Feb 22
Voluntary exchange delisting
4:05pm
6-K
omoq6i0rg3ciprn5eoay
24 Feb 22
Current report (foreign)
2:13pm
6-K
4e45oc5s 4s2
22 Feb 22
Current report (foreign)
10:00am
6-K
djgmcb1y jr685
14 Feb 22
Current report (foreign)
12:00am
6-K
etotqr
1 Feb 22
Current report (foreign)
10:00am
6-K
0s517e0dppyn8j 4f
13 Jan 22
Biofrontera announces preliminary revenue figures for the full year 2021
9:26am
6-K
y31m2z
29 Dec 21
Current report (foreign)
6:20am
6-K
sdph1zkv3m sp3
14 Dec 21
Annual General Meeting
2:24pm
6-K
2uh0fv
13 Dec 21
Current report (foreign)
10:22am
6-K
vux9n3
8 Dec 21
Biofrontera AG obtains notice of allowance for US patent on PDT-lamp and treatment method
8:43am
6-K
gm0bbxhd50x5
2 Dec 21
Biofrontera obtains notice of allowance for US patent on innovative illumination protocol
10:01am
6-K
0lcbiht18q
2 Dec 21
Biofrontera AG announces timing of the departure of the CEO
7:37am
6-K
kzr6e2
2 Dec 21
Current report (foreign)
12:00am
6-K
pfy5q
30 Nov 21
Addition to the agenda of the Annual General Meeting on 14 December 2021 pursuant to section 122 (2) AktG at the request of a shareholder
12:21pm
6-K
jr5 iyfhq7g
29 Nov 21
Current report (foreign)
1:13pm